This WHO manual provides practical tools to help national programmes for neglected tropical diseases (NTDs) plan, prepare, and monitor the safe administration of medicines for the treatment of these diseases.
Visit siteIn her report to the 47th Session of the Human Rights Council, the Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members, Alice Cruz, addresses the disproportionate impact of the coronavirus disease (COVID-19) pandemic on persons affected by leprosy and their family members, exploring the underlying causes and offering constructive recommendations for an inclusive recovery. This factsheet summarizes the key points from the report.
DownloadGlobal Partnership for Zero Leprosy Leadership Teleconference – 1 July 2021
DownloadIn this report to the 47th Session of the Human Rights Council, the Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members, Alice Cruz, addresses the disproportionate impact of the coronavirus disease (COVID-19) pandemic on persons affected by leprosy and their family members, exploring the underlying causes and offering constructive recommendations for an inclusive recovery.
ENG ESP FRGlobal Partnership for Zero Leprosy Leadership Teleconference – 3 June 2021
DownloadGlobal Partnership for Zero Leprosy Leadership Teleconference – 6 May 2021
DownloadGlobal Partnership for Zero Leprosy Leadership Teleconference – 7 April 2021
DownloadThe World Health Organization’s Global Leprosy Strategy 2021 – 2030, “Toward Zero Leprosy,” outlines global targets for 2030 and includes 4 strategic pillars.
Visit siteGlobal Partnership for Zero Leprosy Leadership Team Biannual Conference – 17 – 18 March 2021 Teleconference
DownloadThe WHO Global Leprosy Programme has re-released a report with additional information on the use of thalidomide for the treatment of ENL reactions. The guidance supports the use of thalidomide as a ‘steroid-sparing’ medication for ENL.
Visit siteA new publication from the Pan American Health Organization (PAHO) focuses on DMDI (disease management, disability and inclusion) for four NTDs: leprosy, lymphatic filariasis, trachoma, and Chagas disease.
Visit siteWorld Leprosy Day is recognized internationally on the last Sunday of January to increase the public awareness of leprosy, also known as Hansen’s disease. This slideshow showcases ways the leprosy community celebrated World Leprosy Day in 2021.
Visit siteOur 2020 impact report highlights our work in COVID-19 response, leprosy research, and country partnerships.
DownloadGlobal Partnership for Zero Leprosy Leadership Team Meeting – February 2021 Teleconference
DownloadThe Zero Leprosy Research Agenda was published in Infectious Diseases of Poverty.
Visit siteVisit the Zero Leprosy COVID-19 hub for the latest advice, resources, and news related to leprosy during the COVID-19 pandemic.
Visit siteRead the July – December 2020 issue of The Star, radiating the light of truth on Hansen’s disease. The purpose of The Star is to: 1) Promote an educated public opinion of Hansen’s disease. 2.) Serve as advocate for those who have experienced or been impacted by Hansen’s disease. 3) Foster self-empowerment of those who have experienced Hansen’s disease.
Reprinted with permission from The Star, Carville, Louisiana.
A report from GPZL’s Emergency Response Working Group 2, published in the December 2020 issue of Leprosy Review.
Visit siteA report from GPZL’s Leprosy Emergency Operations Committee (LEOC), published in the December 2020 issue of Leprosy Review.
Visit site